Literature DB >> 6317087

Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex.

P C Comp, R R Nixon, C T Esmon.   

Abstract

Protein C is a vitamin K-dependent plasma protein. Activated protein C is a potent anticoagulant and enhances blood clot lysis. We have developed a functional assay for protein C in human plasma. The measurement of protein C is accomplished by the addition of thrombomodulin, an endothelial-cell-associated cofactor for protein C activation, and thrombin in a 1:1 molar complex. The activated protein C formed in the plasma is immunoadsorbed with goat anti-human protein C IgG-agarose. The immunoadsorbed activated protein C retains the ability to hydrolyze chromogenic substrates, and after unbound plasma proteins are removed by washing, the bound activated protein C is quantitated by incubation with the substrate H-D-phe-pip-arg-p-nitroanilide (S-2238). Normal individuals have functional protein C levels of 3.9-5.9 micrograms/ml, with a mean value of 4.8 micrograms/ml. Individuals undergoing warfarin anticoagulation and patients with advanced liver diseases have decreased levels, as do certain patients with evidence of intravascular clotting. Functional protein C levels correlate well with immunologic levels of the protein in the patient groups studied. Heparin enhances the rate of activated protein C inhibition, as monitored by recovery of activated protein C by immunoadsorption. A patient with recurrent venous thrombosis and abnormal functional protein C activity, but normal levels of antigen, has been identified.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6317087

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

2.  Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.

Authors:  I B Johnstone; C A Martin
Journal:  Can J Vet Res       Date:  2000-04       Impact factor: 1.310

3.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.

Authors:  P P Nawroth; D A Handley; C T Esmon; D M Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.

Authors:  S Vigano D'Angelo; P C Comp; C T Esmon; A D'Angelo
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

5.  Successful treatment of homozygous protein C deficiency by hepatic transplantation.

Authors:  J F Casella; J H Lewis; F A Bontempo; B J Zitelli; H Markel; T E Starzl
Journal:  Lancet       Date:  1988-02-27       Impact factor: 79.321

Review 6.  Clinical relevance of protein C.

Authors:  I Pabinger
Journal:  Blut       Date:  1986-08

7.  Familial protein S deficiency is associated with recurrent thrombosis.

Authors:  P C Comp; R R Nixon; M R Cooper; C T Esmon
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

8.  [The clinical importance of protein C and S deficiency for surgical patients].

Authors:  H Rabl; H Fruhwirth
Journal:  Langenbecks Arch Chir       Date:  1992

9.  Specificity of activated human protein C.

Authors:  S R Stone; J Hofsteenge
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

10.  A simplified functional assay for protein C in plasma samples.

Authors:  W Thiel; K T Preissner; U Delvos; G Müller-Berghaus
Journal:  Blut       Date:  1986-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.